Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,038
Closed -$100K 189
2024
Q1
$100K Buy
+3,038
New +$103K 0.01% 187
2023
Q4
Sell
-3,047
Closed -$112K 178
2023
Q3
$112K Hold
3,047
0.01% 168
2023
Q2
$117K Buy
+3,047
New +$113K 0.01% 177
2020
Q4
Sell
-7,188
Closed -$125K 147
2020
Q3
$125K Sell
7,188
-5,904
-45% -$103K 0.02% 124
2020
Q2
$215K Sell
13,092
-843
-6% -$12.8K 0.04% 96
2020
Q1
$126K Sell
13,935
-4,128
-23% -$83.1K 0.03% 120
2019
Q4
$384K Buy
18,063
+8,744
+94% +$194K 0.07% 104
2019
Q3
$214K Sell
9,319
-932
-9% -$21.2K 0.05% 111
2019
Q2
$249K Buy
+10,251
New +$211K 0.06% 109
2019
Q1
Sell
-14,679
Closed -$221K 128
2018
Q4
$221K Sell
14,679
-1,553
-10% -$40.2K 0.06% 122
2018
Q3
$638K Sell
16,232
-502
-3% -$22.6K 0.16% 78
2018
Q2
$823K Sell
16,734
-568
-3% -$32.2K 0.22% 71
2018
Q1
$1.03M Sell
17,302
-94
-0.5% -$6.27K 0.29% 69
2017
Q4
$1.37M Buy
17,396
+9,371
+117% +$756K 0.4% 63
2017
Q3
$674K Buy
8,025
+196
+3% +$13.9K 0.22% 73
2017
Q2
$512K Buy
7,829
+1,575
+25% +$107K 0.18% 85
2017
Q1
$454K Buy
6,254
+1,413
+29% +$92.8K 0.17% 85
2016
Q4
$284K Buy
+4,841
New +$256K 0.11% 101

Other funds holding ADNT

Blue Chip Partners's ADNT Position: Q2 2024 in Review

Blue Chip Partners sold out of Adient (ADNT) in Q2 2024, closing a stake of 3,038 shares — an estimated $100K sold.

Blue Chip Partners first reported a position in ADNT in Q4 2016 and held it in 18 quarters. The position peaked at $1.37M in Q4 2017. 279 funds tracked by Wall St. Rank hold ADNT as of Q2 2024.

  • Blue Chip Partners reported no remaining Adient position as of Q2 2024 after selling out during the quarter.
  • Blue Chip Partners sold 3,038 Adient shares in Q2 2024, an estimated $100K.
  • Blue Chip Partners first reported a position in Adient in Q4 2016 and held it in 18 quarters.
  • Blue Chip Partners's Adient position peaked at $1.37M in Q4 2017.
  • 279 funds tracked by Wall St. Rank held Adient as of Q2 2024.

Based on Blue Chip Partners's 13F filing for Q2 2024, filed 29 Jul 2024.